TRV GP III, LLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
TRV GP III, LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,688,000
-22.8%
1,148,7800.0%1.17%
-17.6%
Q2 2022$3,481,000
-55.4%
1,148,7800.0%1.42%
-32.7%
Q1 2022$7,800,000
-18.7%
1,148,7800.0%2.12%
-11.8%
Q4 2021$9,592,000
-57.7%
1,148,780
-62.3%
2.40%
-44.2%
Q3 2021$22,652,000
+9.3%
3,048,7800.0%4.30%
+18.8%
Q2 2021$20,732,000
-33.8%
3,048,7800.0%3.62%
-8.6%
Q1 2021$31,311,000
+46.7%
3,048,7800.0%3.96%
+116.1%
Q4 2020$21,342,000
-14.2%
3,048,7800.0%1.83%
-12.3%
Q3 2020$24,878,000
+18.3%
3,048,7800.0%2.09%
-31.9%
Q2 2020$21,037,000
+45.3%
3,048,7800.0%3.07%
-22.1%
Q1 2020$14,482,000
-45.6%
3,048,7800.0%3.94%
-66.5%
Q4 2019$26,616,000
+162.2%
3,048,7800.0%11.75%
+104.3%
Q3 2019$10,152,000
-32.7%
3,048,7800.0%5.75%
-10.3%
Q2 2019$15,091,000
-20.2%
3,048,7800.0%6.42%
-30.7%
Q1 2019$18,902,000
+84.0%
3,048,7800.0%9.26%
+7.6%
Q4 2018$10,274,000
-48.2%
3,048,7800.0%8.61%
-2.7%
Q3 2018$19,817,000
-15.1%
3,048,7800.0%8.85%
+13.8%
Q2 2018$23,354,000
-65.7%
3,048,7800.0%7.78%
-68.3%
Q1 2018$68,140,000
+75.3%
3,048,7800.0%24.53%
+80.2%
Q4 2017$38,872,0003,048,78013.61%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,087,961$2,012,7281.74%
Opaleye Management Inc. 2,880,000$5,328,0001.60%
TANG CAPITAL MANAGEMENT LLC 5,300,087$9,805,1611.46%
Ardent Capital Management, Inc. 923,463$1,708,4071.23%
Beryl Capital Management LLC 610,831$1,130,0370.89%
Arena Investors LP 610,639$1,129,6820.88%
Omega Fund Management, LLC 275,513$509,6990.33%
Deep Track Capital, LP 4,259,653$7,880,3580.32%
PenderFund Capital Management Ltd. 246,310$6160.19%
GABELLI & Co INVESTMENT ADVISERS, INC. 425,100$786,4350.15%
View complete list of JOUNCE THERAPEUTICS INC shareholders